CCDC37 is a notable protein implicated in the structural and functional integrity of cilia and flagella, the cellular appendages vital for mobility and signaling among cells. While the specific roles and mechanisms of CCDC37 within these cellular structures are yet to be thoroughly elucidated, its importance cannot be overstated, thus paving the way for the conceptual exploration of CCDC37 inhibitors.
The term CCDC37 inhibitors denotes a class of compounds posited to inhibit the function or expression of CCDC37, thereby impacting the assembly or functionality of cilia and flagella. The inhibition could be achieved through various molecular mechanisms. These might include the hindrance of CCDC37 gene transcription, the blockade of its mRNA translation, or the direct inhibition of the CCDC37 protein activity. Despite these theoretical underpinnings, the realm of CCDC37 inhibitors remains largely uncharted in scientific literature, awaiting the rigorous investigations that might unveil the exact compounds capable of inhibiting CCDC37 and the mechanisms through which they operate.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib may inhibit the phosphorylation of CCDC37 by acting as a tyrosine kinase inhibitor, potentially affecting its activity in cilia or flagella assembly. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib may inhibit the proteasome, potentially leading to the accumulation of misfolded or damaged CCDC37, thereby reducing the availability of functional protein for cilia or flagella function. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat may inhibit histone deacetylases (HDACs), potentially increasing the acetylation of histones associated with the CFAP100 gene, altering its expression, and reducing CCDC37 protein levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may inhibit RNA polymerase by binding to DNA, potentially reducing the transcription of the CCDC37 gene, leading to lower levels of CCDC37 mRNA and protein. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine may inhibit microtubule formation, potentially impacting the assembly or function of cilia or flagella, thereby indirectly affecting the role of CCDC37 in these structures. | ||||||